Fig. 2From: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phaseThe model performs well and correctly at low and in high risk as shown in calibration plot. The linear regression model has a slope of 0.96 (95% C.I. 0.98/1.40) and a constant of -13.8 between predicted and actual probabilities (95%C.I. -22.9/-4.85)Back to article page